Cardiac Ischemia Detection Using ST Segment and QT Interval Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cardiac ischemia detection techniques relying on ST segment elevation are unreliable due to systemic influences like hypoglycemia, hyperglycemia, and electrolyte imbalances, and existing implantable devices face processing burdens in analyzing QTmax and QTend intervals for accurate detection.
Innovation Solution
A two-tier detection procedure is implemented, where an implanted device provides a preliminary indication of cardiac ischemia based on ST segment elevation, followed by additional analysis using QTmax and QTend intervals, either by the device or a centralized system, to confirm the detection and distinguish it from hypoglycemia, hyperglycemia, and hyperkalemia.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If ST segment elevation is used for cardiac ischemia detection, then detection simplicity is improved, but detection reliability deteriorates due to interference from hypoglycemia, hyperglycemia, and electrolyte imbalances
Solution Approach 1:
The detection process is divided into two distinct stages: a first tier using ST segment elevation for preliminary detection, and a second tier using QTmax and QTend interval analysis for confirmation. This segmentation allows the system to maintain simplicity in the initial screening while ensuring reliability through more specific confirmatory analysis only when needed.
Solution Approach 2:
The system performs preliminary detection using the simple ST segment elevation method first, then conditionally performs the more complex QTmax and QTend analysis only when ischemia is suspected. This preliminary action approach avoids unnecessary complex processing while ensuring reliable detection when needed.
2Measurement precision
If QTmax and QTend interval analysis is performed by the implanted device, then detection precision is improved, but device processing burden increases
Solution Approach 1:
The analysis is segmented into a simple first tier performed by the implanted device (ST segment elevation) and a more complex second tier (QTmax and QTend interval analysis) that can be performed by an external centralized system. This segmentation reduces the processing burden on the implanted device while maintaining high detection precision through comprehensive analysis.
Solution Approach 2:
An external centralized system acts as an intermediary to perform the complex QTmax and QTend interval analysis. This intermediary approach allows the implanted device to remain simple while still achieving high detection precision through the external system's computational capabilities.
3Reliability
If additional implantable devices are used for comprehensive detection, then detection reliability is improved, but patient risk increases
Solution Approach 1:
The implanted device is designed to perform multiple functions: it can detect ST segment elevation, transmit data externally, and potentially perform QTmax and QTend analysis if equipped. This multi-functionality allows comprehensive detection using existing infrastructure rather than requiring additional separate devices, thereby maintaining reliability while minimizing patient risk.
Data Source
AI summary
Techniques are described for efficiently detecting and distinguishing among cardiac ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. In one example, a preliminary indication of an episode of cardiac ischemia is detected based on shifts in ST segment elevation within the IEGM. In response, the implanted device then records additional IEGM data for transmission to an external system. The external system analyzes the additional IEGM data to confirm the detection of cardiac ischemia using a more sophisticated analysis procedure exploiting additional detection parameters. In particular, the external system uses detection parameters capable of distinguishing hypoglycemia, hyperglycemia and hyperkalemia from cardiac ischemia, such as QTmax and QTend intervals. Alternatively, the more sophisticated analysis procedure may be performed by the device itself, if it is so equipped. Other examples described herein pertain instead to the detection of atrial fibrillation.